1 Study Coverage
1.1 Drospirenone and Ethinylestradiol Tablets Product Introduction
1.2 Market by Type
1.2.1 Global Drospirenone and Ethinylestradiol Tablets Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 With 30 μg Ethinylestradiol
1.2.3 With 20 μg Ethinylestradiol
1.3 Market by Application
1.3.1 Global Drospirenone and Ethinylestradiol Tablets Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Birth Control
1.3.3 Moderate Acne
1.3.4 Premenstrual Syndrome (PMS)
1.3.5 Premenstrual Dysphoric Disorder (PMDD)
1.3.6 Dysmenorrhea
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drospirenone and Ethinylestradiol Tablets Sales Estimates and Forecasts 2017-2028
2.2 Global Drospirenone and Ethinylestradiol Tablets Revenue Estimates and Forecasts 2017-2028
2.3 Global Drospirenone and Ethinylestradiol Tablets Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Drospirenone and Ethinylestradiol Tablets Sales by Region
2.4.1 Global Drospirenone and Ethinylestradiol Tablets Sales by Region (2017-2022)
2.4.2 Global Sales Drospirenone and Ethinylestradiol Tablets by Region (2023-2028)
2.5 Global Drospirenone and Ethinylestradiol Tablets Revenue by Region
2.5.1 Global Drospirenone and Ethinylestradiol Tablets Revenue by Region (2017-2022)
2.5.2 Global Drospirenone and Ethinylestradiol Tablets Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drospirenone and Ethinylestradiol Tablets Sales by Manufacturers
3.1.1 Global Top Drospirenone and Ethinylestradiol Tablets Manufacturers by Sales (2017-2022)
3.1.2 Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drospirenone and Ethinylestradiol Tablets in 2021
3.2 Global Drospirenone and Ethinylestradiol Tablets Revenue by Manufacturers
3.2.1 Global Drospirenone and Ethinylestradiol Tablets Revenue by Manufacturers (2017-2022)
3.2.2 Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Drospirenone and Ethinylestradiol Tablets Revenue in 2021
3.3 Global Drospirenone and Ethinylestradiol Tablets Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drospirenone and Ethinylestradiol Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drospirenone and Ethinylestradiol Tablets Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drospirenone and Ethinylestradiol Tablets Sales by Type
4.1.1 Global Drospirenone and Ethinylestradiol Tablets Historical Sales by Type (2017-2022)
4.1.2 Global Drospirenone and Ethinylestradiol Tablets Forecasted Sales by Type (2023-2028)
4.1.3 Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type (2017-2028)
4.2 Global Drospirenone and Ethinylestradiol Tablets Revenue by Type
4.2.1 Global Drospirenone and Ethinylestradiol Tablets Historical Revenue by Type (2017-2022)
4.2.2 Global Drospirenone and Ethinylestradiol Tablets Forecasted Revenue by Type (2023-2028)
4.2.3 Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Type (2017-2028)
4.3 Global Drospirenone and Ethinylestradiol Tablets Price by Type
4.3.1 Global Drospirenone and Ethinylestradiol Tablets Price by Type (2017-2022)
4.3.2 Global Drospirenone and Ethinylestradiol Tablets Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Drospirenone and Ethinylestradiol Tablets Sales by Application
5.1.1 Global Drospirenone and Ethinylestradiol Tablets Historical Sales by Application (2017-2022)
5.1.2 Global Drospirenone and Ethinylestradiol Tablets Forecasted Sales by Application (2023-2028)
5.1.3 Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2017-2028)
5.2 Global Drospirenone and Ethinylestradiol Tablets Revenue by Application
5.2.1 Global Drospirenone and Ethinylestradiol Tablets Historical Revenue by Application (2017-2022)
5.2.2 Global Drospirenone and Ethinylestradiol Tablets Forecasted Revenue by Application (2023-2028)
5.2.3 Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Application (2017-2028)
5.3 Global Drospirenone and Ethinylestradiol Tablets Price by Application
5.3.1 Global Drospirenone and Ethinylestradiol Tablets Price by Application (2017-2022)
5.3.2 Global Drospirenone and Ethinylestradiol Tablets Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drospirenone and Ethinylestradiol Tablets Market Size by Type
6.1.1 North America Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2028)
6.1.2 North America Drospirenone and Ethinylestradiol Tablets Revenue by Type (2017-2028)
6.2 North America Drospirenone and Ethinylestradiol Tablets Market Size by Application
6.2.1 North America Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2028)
6.2.2 North America Drospirenone and Ethinylestradiol Tablets Revenue by Application (2017-2028)
6.3 North America Drospirenone and Ethinylestradiol Tablets Market Size by Country
6.3.1 North America Drospirenone and Ethinylestradiol Tablets Sales by Country (2017-2028)
6.3.2 North America Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Drospirenone and Ethinylestradiol Tablets Market Size by Type
7.1.1 Europe Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2028)
7.1.2 Europe Drospirenone and Ethinylestradiol Tablets Revenue by Type (2017-2028)
7.2 Europe Drospirenone and Ethinylestradiol Tablets Market Size by Application
7.2.1 Europe Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2028)
7.2.2 Europe Drospirenone and Ethinylestradiol Tablets Revenue by Application (2017-2028)
7.3 Europe Drospirenone and Ethinylestradiol Tablets Market Size by Country
7.3.1 Europe Drospirenone and Ethinylestradiol Tablets Sales by Country (2017-2028)
7.3.2 Europe Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drospirenone and Ethinylestradiol Tablets Market Size by Type
8.1.1 Asia Pacific Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2028)
8.1.2 Asia Pacific Drospirenone and Ethinylestradiol Tablets Revenue by Type (2017-2028)
8.2 Asia Pacific Drospirenone and Ethinylestradiol Tablets Market Size by Application
8.2.1 Asia Pacific Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2028)
8.2.2 Asia Pacific Drospirenone and Ethinylestradiol Tablets Revenue by Application (2017-2028)
8.3 Asia Pacific Drospirenone and Ethinylestradiol Tablets Market Size by Region
8.3.1 Asia Pacific Drospirenone and Ethinylestradiol Tablets Sales by Region (2017-2028)
8.3.2 Asia Pacific Drospirenone and Ethinylestradiol Tablets Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Drospirenone and Ethinylestradiol Tablets Market Size by Type
9.1.1 Latin America Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2028)
9.1.2 Latin America Drospirenone and Ethinylestradiol Tablets Revenue by Type (2017-2028)
9.2 Latin America Drospirenone and Ethinylestradiol Tablets Market Size by Application
9.2.1 Latin America Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2028)
9.2.2 Latin America Drospirenone and Ethinylestradiol Tablets Revenue by Application (2017-2028)
9.3 Latin America Drospirenone and Ethinylestradiol Tablets Market Size by Country
9.3.1 Latin America Drospirenone and Ethinylestradiol Tablets Sales by Country (2017-2028)
9.3.2 Latin America Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Drospirenone and Ethinylestradiol Tablets Market Size by Type
10.1.1 Middle East and Africa Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2028)
10.1.2 Middle East and Africa Drospirenone and Ethinylestradiol Tablets Revenue by Type (2017-2028)
10.2 Middle East and Africa Drospirenone and Ethinylestradiol Tablets Market Size by Application
10.2.1 Middle East and Africa Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2028)
10.2.2 Middle East and Africa Drospirenone and Ethinylestradiol Tablets Revenue by Application (2017-2028)
10.3 Middle East and Africa Drospirenone and Ethinylestradiol Tablets Market Size by Country
10.3.1 Middle East and Africa Drospirenone and Ethinylestradiol Tablets Sales by Country (2017-2028)
10.3.2 Middle East and Africa Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Camber Pharmaceuticals
11.1.1 Camber Pharmaceuticals Corporation Information
11.1.2 Camber Pharmaceuticals Overview
11.1.3 Camber Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Camber Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Camber Pharmaceuticals Recent Developments
11.2 Aurobindo Pharma
11.2.1 Aurobindo Pharma Corporation Information
11.2.2 Aurobindo Pharma Overview
11.2.3 Aurobindo Pharma Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Aurobindo Pharma Drospirenone and Ethinylestradiol Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Aurobindo Pharma Recent Developments
11.3 Teva Generics
11.3.1 Teva Generics Corporation Information
11.3.2 Teva Generics Overview
11.3.3 Teva Generics Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Teva Generics Drospirenone and Ethinylestradiol Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Generics Recent Developments
11.4 Glenmark Pharmaceuticals
11.4.1 Glenmark Pharmaceuticals Corporation Information
11.4.2 Glenmark Pharmaceuticals Overview
11.4.3 Glenmark Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Glenmark Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Glenmark Pharmaceuticals Recent Developments
11.5 Xiromed
11.5.1 Xiromed Corporation Information
11.5.2 Xiromed Overview
11.5.3 Xiromed Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Xiromed Drospirenone and Ethinylestradiol Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Xiromed Recent Developments
11.6 Wellona Pharma
11.6.1 Wellona Pharma Corporation Information
11.6.2 Wellona Pharma Overview
11.6.3 Wellona Pharma Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Wellona Pharma Drospirenone and Ethinylestradiol Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Wellona Pharma Recent Developments
11.7 Barr Pharmaceuticals, Inc.
11.7.1 Barr Pharmaceuticals, Inc. Corporation Information
11.7.2 Barr Pharmaceuticals, Inc. Overview
11.7.3 Barr Pharmaceuticals, Inc. Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Barr Pharmaceuticals, Inc. Drospirenone and Ethinylestradiol Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Barr Pharmaceuticals, Inc. Recent Developments
11.8 Hetero Drugs
11.8.1 Hetero Drugs Corporation Information
11.8.2 Hetero Drugs Overview
11.8.3 Hetero Drugs Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Hetero Drugs Drospirenone and Ethinylestradiol Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hetero Drugs Recent Developments
11.9 MYLAN LABS LTD.
11.9.1 MYLAN LABS LTD. Corporation Information
11.9.2 MYLAN LABS LTD. Overview
11.9.3 MYLAN LABS LTD. Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 MYLAN LABS LTD. Drospirenone and Ethinylestradiol Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 MYLAN LABS LTD. Recent Developments
11.10 Bayer Weimar GmbH und Co. KG
11.10.1 Bayer Weimar GmbH und Co. KG Corporation Information
11.10.2 Bayer Weimar GmbH und Co. KG Overview
11.10.3 Bayer Weimar GmbH und Co. KG Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Bayer Weimar GmbH und Co. KG Drospirenone and Ethinylestradiol Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bayer Weimar GmbH und Co. KG Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drospirenone and Ethinylestradiol Tablets Industry Chain Analysis
12.2 Drospirenone and Ethinylestradiol Tablets Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drospirenone and Ethinylestradiol Tablets Production Mode & Process
12.4 Drospirenone and Ethinylestradiol Tablets Sales and Marketing
12.4.1 Drospirenone and Ethinylestradiol Tablets Sales Channels
12.4.2 Drospirenone and Ethinylestradiol Tablets Distributors
12.5 Drospirenone and Ethinylestradiol Tablets Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drospirenone and Ethinylestradiol Tablets Industry Trends
13.2 Drospirenone and Ethinylestradiol Tablets Market Drivers
13.3 Drospirenone and Ethinylestradiol Tablets Market Challenges
13.4 Drospirenone and Ethinylestradiol Tablets Market Restraints
14 Key Findings in The Global Drospirenone and Ethinylestradiol Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
